Logo image of ALNXT.PA

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

Europe - EPA:ALNXT - FR0004171346 - Common Stock

0.415 EUR
+0 (+0.24%)
Last: 11/18/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALNXT. ALNXT was compared to 72 industry peers in the IT Services industry. The financial health of ALNXT is average, but there are quite some concerns on its profitability. ALNXT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.
ALNXT had a positive operating cash flow in the past year.
ALNXT had positive earnings in each of the past 5 years.
Of the past 5 years ALNXT 4 years had a positive operating cash flow.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

ALNXT has a Return On Assets of 2.83%. This is comparable to the rest of the industry: ALNXT outperforms 43.06% of its industry peers.
ALNXT's Return On Equity of 4.93% is on the low side compared to the rest of the industry. ALNXT is outperformed by 61.11% of its industry peers.
The Return On Invested Capital of ALNXT (6.30%) is worse than 61.11% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALNXT is significantly below the industry average of 11.33%.
The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROIC 6.3%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

ALNXT has a Profit Margin (2.50%) which is in line with its industry peers.
ALNXT's Profit Margin has declined in the last couple of years.
ALNXT's Operating Margin of 5.15% is in line compared to the rest of the industry. ALNXT outperforms 44.44% of its industry peers.
ALNXT's Operating Margin has declined in the last couple of years.
ALNXT has a Gross Margin of 54.19%. This is comparable to the rest of the industry: ALNXT outperforms 44.44% of its industry peers.
ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.
The number of shares outstanding for ALNXT remains at a similar level compared to 1 year ago.
ALNXT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALNXT has an improved debt to assets ratio.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.14 indicates that ALNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.14, ALNXT is in line with its industry, outperforming 44.44% of the companies in the same industry.
The Debt to FCF ratio of ALNXT is 3.10, which is a good value as it means it would take ALNXT, 3.10 years of fcf income to pay off all of its debts.
ALNXT has a Debt to FCF ratio of 3.10. This is comparable to the rest of the industry: ALNXT outperforms 58.33% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ALNXT is not too dependend on debt financing.
ALNXT's Debt to Equity ratio of 0.12 is amongst the best of the industry. ALNXT outperforms 80.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Altman-Z 2.14
ROIC/WACC0.94
WACC6.68%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
ALNXT has a Current ratio of 1.25. This is comparable to the rest of the industry: ALNXT outperforms 55.56% of its industry peers.
A Quick Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.25, ALNXT is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.79% over the past year.
Measured over the past 5 years, ALNXT shows a small growth in Earnings Per Share. The EPS has been growing by 3.66% on average per year.
ALNXT shows a decrease in Revenue. In the last year, the revenue decreased by -2.25%.
ALNXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.48% yearly.
EPS 1Y (TTM)39.79%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%

3.2 Future

ALNXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.47% yearly.
ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.38 indicates a reasonable valuation of ALNXT.
93.06% of the companies in the same industry are more expensive than ALNXT, based on the Price/Earnings ratio.
ALNXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.51.
With a Price/Forward Earnings ratio of 4.48, the valuation of ALNXT can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 95.83% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.98. ALNXT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.38
Fwd PE 4.48
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALNXT is valued a bit cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.87
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

ALNXT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.5
PEG (5Y)2.83
EPS Next 2Y9.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALNXT!.
Industry RankSector Rank
Dividend Yield N/A

NEXTEDIA

EPA:ALNXT (11/18/2025, 7:00:00 PM)

0.415

+0 (+0.24%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap16.19M
Revenue(TTM)62.04M
Net Income(TTM)1.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.38
Fwd PE 4.48
P/S 0.26
P/FCF 8.87
P/OCF 8.47
P/B 0.52
P/tB 13.96
EV/EBITDA N/A
EPS(TTM)0.04
EY9.64%
EPS(NY)0.09
Fwd EY22.34%
FCF(TTM)0.05
FCFY11.28%
OCF(TTM)0.05
OCFY11.81%
SpS1.59
BVpS0.81
TBVpS0.03
PEG (NY)0.5
PEG (5Y)2.83
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROCE 8.85%
ROIC 6.3%
ROICexc 7.81%
ROICexgc N/A
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
FCFM 2.94%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.82%
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.14
F-Score7
WACC6.68%
ROIC/WACC0.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.79%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.12%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y-33.44%
OCF growth 3Y-10.82%
OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.


Can you provide the valuation status for NEXTEDIA?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.


What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALNXT stock?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.


What is the expected EPS growth for NEXTEDIA (ALNXT.PA) stock?

The Earnings per Share (EPS) of NEXTEDIA (ALNXT.PA) is expected to grow by 20.64% in the next year.